Chronic Kidney Disease

can 18F-PET-TT be used as an diagnostic tool in patients with CKD-MBD

18F-PET-TT

Correlation between 18F-Sodium Fluoride positron emission tomography and bone histomorphometry in dialysis patients

TYKS/nefrologia ja dialyysihoidot

Chronic Kidney Disease and Bone - Correlation Between 18F-PET-TT Imaging and Histomorphometry of Bone in CKD Patients

Chronic Kidney Disease and Bone - Correlation Between 18F-PET-TT Imaging and Histomorphometry of Bone in Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism

18F-PET correlates with histomorphometric markers in bone biopsy

Turku University Hospital

Patient receive a dose that is considered within the standard dosing range for Vitamin D3 for one year.

Patients receive a more aggressive Vitamin D3 dosing regimen of 50,000 units weekly for the first 3 months. At this point Vitamin D3 levels are measured. If the patient is Vitamin D3 replete (>75 nmol/L) then the dose is reduced to the equivalent of 25,000 units per week for the next 9 months. If the level is below this threshold then 50,000 units per week is continued for the next 9 months

Renal Insufficiency, Chronic

Vascular Stiffness

Bone Diseases, Metabolic

Vitamin D3

Jewish General Hospital

Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients

Parameter measured as the difference in millimeters in carotid artery diameter between systole and diastole.

Parameter measured as the reactive hyperemia index as calculated by the Endo-PAT2000® system software.

Parameter measured using a semi-quantitative scoring system based on scale of 1-4 as described by Rosenhek et al, New England Journal of Medicine 2000;343 (9):611.
1-no calcification, 2-mildly calcified (small isolated spots), 3-moderately calcified (multiple larger spots), 4-heavily calcified (extensive thickening and calcification of all cusps).

Parameter measured using a semi-quantitative scoring system based on a scale of 0-3 as described by Kauppila et al, Atherosclerosis 1997;132:245.
0-no calcification, 1-small scattered calcific deposits filling less than 1/3 of the longitudinal wall of the aorta, 2-one third or more, but less than two thirds of the longitudinal wall of the aorta calcified, 3-two thirds or more of the longitudinal wall of the aorta calcified.

Osteodensitometry of the lumbar spine, hip, and distal radius, using dual-energy X-ray absorptiometry and reported in grams per square centimeter.

Measurement of parathyroid hormone levels using a commercially available intact parathyroid hormone ELISA kit with values reported in ng/L.

Mark L. Lipman

Associate Professor of Medicine

Chronic Renal Insufficiency

Disorder Related to Renal Transplantation

Metabolic Bone Diseases

Vascular Disease

bone biopsy, echocardiogram, blood samples

transplanted patients

Nephrology Department, Centro Hospitalar de Lisboa Central

Bone and Cardiovascular Disease After Kidney Transplant

Bone Metabolism and Cardiovascular Risk After Kidney Transplant in Adult Patients

left ventricular hypertrophy, myocardial infarction, congestive heart failure, arrhythmia

marchiafava-bignami disease/phosphatase

Chronic Kidney Disease and Bone - Correlation Between 18F-PET-TT Imaging and Histomorphometry of Bone in CKD Patients

Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients

Bone and Cardiovascular Disease After Kidney Transplant

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen